Institution statistics

FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE RECERCA - Spain 

Ranking results:

Past rankings:
2019
Criterium:Position:
Overall Score:400-500
Total Project Funding per Partner:300-400
Total Number of Projects:500-600
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
2017
Criterium:Position:
Overall Score:400-500
Total Project Funding per Partner:300-400
Total Number of Projects:500-600
Networking Rank (Reputation):500-600
2016
Criterium:Position:
Overall Score:500-600
Total Project Funding per Partner:500-600
Total Number of Projects:600-700
Networking Rank (Reputation):600-700
2015
Criterium:Position:
Overall Score:800-900
Total Project Funding per Partner:700-800
Total Number of Projects:800-900
Networking Rank (Reputation):800-900
Partner Constancy:700-800
Project Leadership Index:700-800
2014
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
Ranking timeline:

European project participation (2010-01-01 - 2021-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 45
As coordinator: 6
As participant: 36
Sole participant: 3
Coordinator / Participant Ratio: 0.17*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2021 0 9.999.064 434.000 1
2020 18.258.323 39.692.731 4.949.972 3 7
2019 12.004.953 37.920.546 3.714.168 1 5
2018 0 8.979.119 626.348 2
2017 0 36.744.950 2.990.666 5
2016 0 29.991.564 1.717.060 5
2015 0 40.497.896 816.006 4
2014 173.371 3.687.558 400.052 1 1
2013 100.000 9.306.780 552.457 1 3
2012 6.554.746 21.822.236 2.807.535 2 3
2011 354.900 0 224.700 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE8
STICHTING KATHOLIEKE UNIVERSITEIT8
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS7
KATHOLIEKE UNIVERSITEIT LEUVEN7
KING'S COLLEGE LONDON6
SERVICIO MADRILENO DE SALUD6
UNIVERSITAIR MEDISCH CENTRUM UTRECHT6
ACADEMISCH ZIEKENHUIS GRONINGEN5
CHARITE UNIVERSITAETSMEDIZIN BERLIN5
KAROLINSKA INSTITUTE5
UNIVERSITAETSKLINIKUM HEIDELBERG5
UNIVERSITY COLLEGE LONDON5
UNIVERSITY OF BOLOGNA5
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER4
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK4
REGION HOVEDSTADEN4
TARTU ULIKOOL4
UNIVERSITA DEGLI STUDI DI PADOVA4
UNIVERSITAT DE BARCELONA4
UNIVERSITY OF BERGEN4
ANAXOMICS BIOTECH S L3
COMMISSARIAT A L'ENERGIE ATOMIQUE3
CONCENTRIS RESEARCH MANAGEMENT3
EATRIS ERIC3
EBERHARD KARLS UNIVERSITAET TUEBINGEN3
FEDERATION INTERNATIONALE DU DIABETE REGION EUROPE AISBL3
HOSPICES CIVILS DE LYON3
INSTITUT CATALA DE LA SALUT3
JANSSEN PHARMACEUTICA NV3
JOHANN WOLFGANG GOETHE UNIVERSITAET FRANKFURT3
MEDIZINISCHE HOCHSCHULE HANNOVER3
NOVARTIS PHARMA3
STICHTING VUMC3
STROKE ALLIANCE FOR EUROPE3
THE QUEEN'S UNIVERSITY OF BELFAST3
THE UNIVERSITY OF EDINBURGH3
THE UNIVERSITY OF NOTTINGHAM3
UNIVERSITA DEGLI STUDI DI MILANO3
UNIVERSITAET ULM3
UNIVERSITAET ZUERICH3
UNIVERSITEIT MAASTRICHT3
UNIVERSITY OF BIRMINGHAM3
UNIVERSITY OF GLASGOW3
UNIVERSITY OF HELSINKI3
ACADEMIC MEDICAL CENTRE AMSTERDAM2
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM2
AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS2
ALZHEIMER EUROPE2
BIOKERALTY RESEARCH INSTITUTE AIE2
CENTRE DE REGULACIO GENOMICA2
CENTRE HOSPITALIER SAINTE ANNE DE PARIS2
CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE2
CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS2
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE2
CONSIGLIO NAZIONALE DELLE RICERCHE2
CONSORCIO CENTRO DE INVESTIGACION BIOMEDICA EN RED MP2
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM2
EUROPEAN LIVER PATIENTS ASSOCIATION2
EUROPEAN PATIENTS' FORUM2
EUROSCAN INTERNATIONAL NETWORK EV2
FACULTY OF MEDICINE UNIVERSITY OF BELGRADE2
FAKULTNI NEMOCNICE U SV ANNY V BRNE2
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALLHEBRON2
GABO:MI GESELLSCHAFT FUR ABLAUFORGANISATION:MILLIARIUM MBH & CO KG GAB O2
GOETEBORGS UNIVERSITET2
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE2
INSERM TRANSFERT2
INSTITUT PASTEUR2
JOHANN WOLFGANG GOETHEUNIVERSITATFRANKFURT AM MAIN2
KARLSRUHER INSTITUT FUER TECHNOLOGIE2
KLINIKUM DER UNIVERSITAET ZU KOELN2
LINKOPINGS UNIVERSITET2
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN2
LUXEMBOURG INSTITUTE OF HEALTH2
NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS2
NATIONAL STROKE RESEARCH INSTITUTE2
OSPEDALE PEDIATRICO BAMBINO GESU2
OSPEDALE SAN RAFFAELE2
PFIZER LIMITED2
POLITECNICO DI MILANO2
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON2
RESONANT CIRCUITS LIMITED2
SERVICIO ANDALUZ DE SALUD2
STICHTING KARAKTER2
STICHTING LYGATURE2
STRYKER TRAUMA2
SYDDANSK UNIVERSITET2
TECHNISCHE UNIVERSITAET DRESDEN2
TERVEYDEN JA HYVINVOINNIN LAITOS2
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD2
THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE2
THE EUROPEAN INSTITUTE FOR INNOVATION THROUGH HEALTH DATA2
THE PROVOST FELLOWS FOUNDATION SCHOLARS & THE OTHER MEMBERS OF BOARD OF THE COLLEGE OF THE HOLY & UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN2
THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK2
THE UNIVERSITY OF LIVERPOOL2
THE UNIVERSITY OF MANCHESTER2
THE UNIVERSITY OF SYDNEY2
UNIVERSITA DEGLI STUDI DI PISA2
UNIVERSITA DEGLI STUDI DI TORINO2
UNIVERSITA DEGLI STUDI DI VERONA2
Constancy:

Total number of partners:672

Partner loyalty:
Frequent Partner: (> 2 projects): 178
Rare Partner: 494

Frequent / Rare Partner Ratio: 0.36

Diversity:

Categories:
Category:No:
BIOLOGICAL SCIENCES7
RTD HORIZONTAL TOPICS3
SOCIAL AND ECONOMIC CONCERNS3
INDUSTRY AND TECHNOLOGY1

Project overview:

Start dateProjectacronymrolefundingpartners
2021-01-01Genomics and Personalized Medicine for all though Artificial Intelligence in Haematological Diseases GenoMed4ALLparticipant9.999.06423
2020-10-01Spinal Muscular Atrophy (SMA) beyond motoneuron degeneration: multi-system aspects SMABEYONDparticipant2.142.7358
2020-09-01Self Conversation in Virtual Reality Embodiment to Enhance Healthier Lifestyles Among Obese People SOCRATESparticipant1.748.2084
2020-01-01Erythrocytes properties and viability in dependence of flow and extra-cellular environment EVIDENCEparticipant3.993.48012
2020-01-01DECISION ON OPTIMAL COMBINATORIAL THERAPIES IN IMIDS USING SYSTEMS APPROACHES DocTIScoordinator6.260.05010
2020-01-01Consolidating the capacities of EATRIS-ERIC for Personalised Medicine EATRIS-Plusparticipant4.999.02319
2020-01-01Retinal and cognitive dysfunction in type 2 diabetes: unraveling the common pathways and identification of patients at risk of dementia RECOGNISEDcoordinator5.998.27322
2020-01-01Immune profiling to guide host-directed interventions to cure HBV infections IP-cure-Bparticipant9.983.02914
2020-01-01Development, dIagnostic and prevention of gender-related Somatic and mental COmorbitiEs in iRritable bowel syndrome In Europe DISCOvERIEcoordinator6.000.00019
2020-01-01DIGITAL, RISK-BASED SCREENING FOR ATRIAL FIBRILLATION IN THE EUROPEAN COMMUNITY AFFECT-EUparticipant5.947.92526
2020-01-01Mapping Exposure-Induced Immune Effects: Connecting the Exposome and the Immunome EXIMIOUSparticipant10.878.33115
2019-11-01EU Patient- cEntric clinicAl tRial pLatform EU-PEARLcoordinator12.004.95336
2019-10-01Immune-Image: Specific Imaging of Immune Cell Dynamics Using Novel Tracer Strategies Immune-Imageparticipant15.000.00022
2019-04-01AuTonomous intraLuminAl Surgery ATLASparticipant3.944.50921
2019-04-01SAFETY TESTING IN THE LIFE CYCLE OF NANOTECHNOLOGY-ENABLED MEDICAL TECHNOLOGIES FOR HEALTH. SAFE-N-MEDTECHparticipant14.534.36628
2019-04-01European-Latin American TB Research Collaboration Network EUSAT-RCSparticipant910.8009
2019-01-01Deciphering the fungus-host-microbiota interplay to improve the management of fungal infections FunHoMicparticipant3.530.87118
2018-10-01Evolvable platform for programmable nanoparticle-based cancer therapies EVO-NANOparticipant2.988.6597
2018-01-01Stem-cell based gene therapy for recombination deficient SCID (RECOMB) RECOMBparticipant5.990.46017
2017-12-01PREvention of STroke in Intracerebral haemorrhaGE survivors with Atrial Fibrillation PRESTIGE-AFparticipant6.958.89612
2017-10-01Multimodal nanoparticles for structural and functional tracking of stem cell therapy on muscle regeneration nTRACKparticipant6.863.86512
2017-09-01Effects of Nutrition and Lifestyle on Impulsive, Compulsive, and Externalizing behaviours Eat2beNICEparticipant11.144.56218
2017-01-01SIMVASTATIN AND RIFAXIMIN AS NEW THERAPY FOR PATIENTS WITH DECOMPENSATED CIRRHOSIS LIVERHOPEparticipant5.998.80018
2017-01-01Penumbral Rescue by Normobaric O=O Administration in Patients With Ischaemic Stroke and Target Mismatch ProFile: A Phase II Proof-of-Concept Trial PROOFparticipant5.778.82712
2016-10-01Models Of Patient Engagement for Alzheimer’s Disease - Sofia ref.: 115985 MOPEADparticipant2.043.00015
2016-04-01Remote Assessment of Disease and Relapse in Central Nervous System Disorders - Sofia ref.: 115902 RADAR-CNSparticipant11.000.00025
2016-04-01Nanomedicine upscaling for early clinical phases of multimodal cancer therapy NoCanTherparticipant7.113.77912
2016-01-01Comorbid Conditions of Attention deficit / hyperactivity disorder CoCAparticipant5.999.02117
2016-01-01Brain injury and trauma monitoring using advanced photonics BitMapparticipant3.835.76411
2015-09-01REgenerative Stem cell therapy for STroke in Europe RESSTOREparticipant6.338.25931
2015-08-01iABC Programme IABC PROGRAMMEparticipant24.331.60922
2015-05-01Clinical evaluation of carbons of controlled porosity as a new therapeutic for the treatment of liver cirrhosis and non-alcoholic fatty liver disease. CARBALIVEparticipant5.913.08014
2015-01-01Mastering skills in the training Network for attention deficit hyperactivity and autism spectrum Disorders MiNDparticipant3.914.94812
2014-04-01Unraveling metabolic settings and targeting metabolic enzymes with selective lethality in BRAF and NRAS mutant melanoma tumors METABOSETcoordinator173.3711
2014-02-01European Training in Neural Regulation of Intestinal Function NEUROGUTparticipant3.687.55812
2013-11-01PREventive Care Infrastructure based On Ubiquitous Sensing PRECIOUSparticipant2.808.9998
2013-11-01Aggression subtyping for improved insight and treatment innovation in psychiatric disorders AGGRESSOTYPEparticipant6.000.00023
2013-10-01New epigenetic therapy for high-risk neuroblastoma MIRNATHERAPYNBLcoordinator100.0001
2013-09-01Multicentre Preclinical Animal Research Team MULTI-PARTparticipant497.78112
2012-11-01Best EScalation Treatment in Multiple Sclerosis (MS) BEST MSparticipant4.880.5755
2012-09-01INCOMING FELLOWSHIPS BIOMEDICINE INSTITUT DE RECERCA VALL D’HEBRON INCOMEDcoordinator555.9841
2012-03-01European Consortium for the Early Treatment of Diabetic Retinopathy EUROCONDORcoordinator5.998.76218
2012-02-01European multicentre, randomised, phase III clinical trial of hypothermia plus best medical treatment versus best medical treatment alone for acute ischaemic stroke EuroHYP-1participant10.941.66538
2012-01-01Early Prevention of Diabetes Complications in people with Hyperglycaemia in Europe E-PREDICEparticipant5.999.99635
2011-08-01PROTEOMIC IDENTIFICATION OF BIOMARKERS IN BIOFLUIDS AND IN PRECLINICAL MODELS FOR THE EARLY DIAGNOSIS AND PROGNOSIS OF CANCER (PROT*BIO*FLUID) PROTBIOFLUIDcoordinator354.9002
Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum